Rezolute (RZLT) Change in Acquisitions & Divestments (2023 - 2026)
Rezolute (RZLT) posted Change in Acquisitions & Divestments of $49.3 million for Q1 2026, down 0.9% sequentially from $49.7 million in Q4 2025, and up 96.45% YoY from $25.1 million in Q1 2025.
Rezolute (RZLT) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Rezolute has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $49.3 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 96.45% year-over-year to $49.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147.2 million (up 27.81% YoY) and the FY2025 annual result came in at $113.6 million, down 1.3% from the prior year.
- Change in Acquisitions & Divestments eased to $49.3 million in Q1 2026 per RZLT's latest filing, from $49.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $49.7 million in Q4 2025 and troughed at $18.6 million in Q3 2023.
- A 4-year average of $31.6 million and a median of $27.8 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments decreased 14.39% in 2025, then surged 96.45% in 2026.
- Over 4 years, Change in Acquisitions & Divestments stood at $41.9 million in 2023, then dropped by 11.99% to $36.9 million in 2024, then surged by 34.69% to $49.7 million in 2025, then retreated by 0.9% to $49.3 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $49.3 million, $49.7 million, and $20.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.25 Mn |
| Mar 31, 2026 | 49.25 Mn |
| Dec 31, 2025 | 49.70 Mn |
| Dec 31, 2025 | 49.70 Mn |
| Sep 30, 2025 | 20.40 Mn |
| Sep 30, 2025 | 20.40 Mn |
| Jun 30, 2025 | 27.80 Mn |
| Jun 30, 2025 | 27.80 Mn |
| Mar 31, 2025 | 25.07 Mn |
| Mar 31, 2025 | 25.07 Mn |
| Dec 31, 2024 | 36.90 Mn |
| Dec 31, 2024 | 36.90 Mn |
| Sep 30, 2024 | 23.83 Mn |
| Sep 30, 2024 | 23.83 Mn |
| Jun 30, 2024 | 29.33 Mn |
| Jun 30, 2024 | 29.33 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Dec 31, 2023 | 41.93 Mn |
| Dec 31, 2023 | 41.93 Mn |